Abiraterone Acetate Tablet
Product Images NDC 69238-1754

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 69238-1754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Abiraterone Acetate Tablets 250mg 500mg 1

Abiraterone Acetate Tablets 250mg 500mg 1
Chemical structure of abiraterone acetate, showing its detailed molecular arrangement including rings, methyl groups, and an acetate group as represented in the diagram.*
FDA Label Image

Abiraterone Acetate Tablets 250mg 500mg 2

Abiraterone Acetate Tablets 250mg 500mg 2
A survival curve chart comparing the percentage of survival over time in months between two groups: Abiraterone Acetate and Placebo. The x-axis represents time to death in months, and the y-axis shows the percentage of survival from 0 to 100%. The chart includes data points and a legend distinguishing the two groups with different line styles.*
FDA Label Image

Abiraterone Acetate Tablets 250mg 500mg 3

Abiraterone Acetate Tablets 250mg 500mg 3
A survival curve chart depicting the percentage of subjects without death over months from randomization, comparing Abiraterone Acetate to Placebo. The x-axis shows months from 0 to 60 and the y-axis shows percent subjects without death from 0 to 100. Two curves, labeled for Placebo and Abiraterone Acetate, show a gradual decline with Abiraterone Acetate having a higher survival percentage across the timeline.*
FDA Label Image

Abiraterone Acetate Tablets 250mg 500mg 4

Abiraterone Acetate Tablets 250mg 500mg 4
A Kaplan-Meier survival curve comparing the percentage of subjects without radiographic progression or death over months from randomization between Abiraterone Acetate and placebo groups. The graph shows two lines, one solid for Abiraterone Acetate and one dashed for placebo, with subject numbers listed below at time intervals.*
FDA Label Image

Abiraterone Acetate Tablets 250mg 500mg 5

Abiraterone Acetate Tablets 250mg 500mg 5
A Kaplan-Meier survival curve chart depicting the percentage of subjects without death over time in months from randomization. It compares two groups: Abiraterone acetate and placebo, with subject counts at risk listed below the horizontal axis at various intervals up to 66 months. The solid line represents Abiraterone acetate, and the dashed line represents placebo.*
FDA Label Image

Abiraterone Acetate Tablets 250mg 500mg 6

Abiraterone Acetate Tablets 250mg 500mg 6
Label for Abiraterone Acetate Tablets, USP 250 mg oral tablets by Amneal Pharmaceuticals LLC, containing 120 tablets. The label includes a warning for pregnant women, storage instructions, and shows an oval tablet imprinted with 'AN65'.*
FDA Label Image

Abiraterone Acetate Tablets 250mg 500mg 7

Abiraterone Acetate Tablets 250mg 500mg 7
Label for Abiraterone Acetate Tablets, USP 500 mg by Amneal Pharmaceuticals LLC. The film-coated tablets are oval and tan-colored imprinted with '1754'. The carton contains 60 tablets. Storage instructions and a barcode are also present on the label, along with dosing direction to see the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.